Yatender Kumar
Overview
Explore the profile of Yatender Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saini S, Kumar Y
J Biomol Struct Dyn
. 2024 Jan;
:1-14.
PMID: 38173178
Antibodies are crucial tools in various biomedical applications, including immunotherapy. In this study, we focused on designing and engineering antibodies to enhance their structural dynamics and functional properties. By employing...
2.
Saini S, Pareekh S, Kumar Y
J Biomol Struct Dyn
. 2023 Jun;
42(9):4668-4678.
PMID: 37334729
The SARS-CoV-2 Variant B.1.1.5291 evolved rapidly in late November 2021 from the existing mutants sparking fear worldwide owing to its infamous immune escape from a varied class of neutralising antibodies....
3.
Singh V, Singh N, Pradhan A, Kumar Y, Bhatnagar S
Comput Biol Med
. 2023 May;
161:107004.
PMID: 37230015
Background: Human neutrophil elastase (HNE) is a key driver of systemic and cardiopulmonary inflammation. Recent studies have established the existence of a pathologically active auto-processed form of HNE with reduced...
4.
Singh S, Sasmal S, Kumar Y
Appl Biochem Biotechnol
. 2023 May;
196(2):841-877.
PMID: 37223872
Over the past century, chemicals and energy have increasingly been derived from non-renewable resources. The growing demand for essential chemicals and shrinking inventory make reliable, sustainable sources essential. Carbohydrates offer...
5.
Singh S, Kumar Y, Sasmal S
Curr Microbiol
. 2022 Nov;
79(12):395.
PMID: 36352327
Enhancement in algal biomass production is a crucial parameter for generating value-added chemicals from renewable carbon sources. This study aimed to fabricate a novel photobioreactor with integrated and innovative electromagnets...
6.
Saini S, Agarwal M, Pradhan A, Pareek S, Singh A, Dhawan G, et al.
J Biomol Struct Dyn
. 2022 Jan;
41(6):2341-2354.
PMID: 35098888
Cross-reactive and broadly neutralizing antibodies against surface proteins of diverse strains of rapidly evolving viral pathogens like SARS-CoV-2 can prevent infection and therefore are crucial for the development of effective...
7.
Adhikarla S, Jha N, Goswami V, Sharma A, Bhardwaj A, Dey A, et al.
Brain Sci
. 2021 Nov;
11(11).
PMID: 34827372
A special class of proteins called Toll-like receptors (TLRs) are an essential part of the innate immune system, connecting it to the adaptive immune system. There are 10 different Toll-Like...
8.
Sharma A, Anand J, Kumar Y
CNS Neurol Disord Drug Targets
. 2021 Sep;
21(9):752-765.
PMID: 34477533
Alzheimer's Disease (AD), often called the 'Plague of the 21st Century,' is a progressive, irreversible neurodegenerative disorder that leads to the degeneration and death of neurons. Multiple factors, such as...
9.
Kailoo S, Shreya , Kumar Y
World J Microbiol Biotechnol
. 2021 Aug;
37(9):150.
PMID: 34379213
Cytolethal Distending Toxin (CDT) belongs to the AB toxin family and is produced by a plethora of Gram-negative bacteria. Eight human-affecting enteropathogens harbor CDT that causes irritable bowel syndrome (IBS),...
10.
Gupta A, Kumar Y
Hum Vaccin Immunother
. 2020 Jul;
16(11):2831-2839.
PMID: 32614706
Many types of cancers are prevalent in India and worldwide. Monoclonal antibodies (MAbs) are one of the major types of cancer therapeutics, which have included MAbs of hybridoma, chimeric, humanized,...